We are excited to announce that Ecumenical Pharmaceutical Network and HATCH Technologies have officially affirmed their partnership through the signing and exchange of Memorandums of Understanding (MOUs). This strategic collaboration will guide our joint efforts in the implementation of the Maternal, Newborn, and Child Health (MNCH) project implemented in Kenya and Nigeria. The project aimed to reduce maternal and neonatal mortality by introducing innovative solutions to prevent postpartum haemorrhage (PPH) and neonatal complications during birth.
As part of this partnership, HATCH Technologies will distribute:
These devices will play a critical role in saving newborn lives by providing safe and effective respiratory support for infants struggling with breathing difficulties at birth. By equipping the faith based health facilities with life-saving innovations, we are bridging the gap in neonatal care and ensuring that even the most vulnerable newborns receive the care they need right from the start.
This partnership establishes clear roles and responsibilities, ensuring seamless implementation of the project and maximizing impact in faith-based health facilities. We look forward to continue working together with HATCH Technologies, CHAK, and CHAN to drive real change in maternal and newborn health.
Together, we are making a difference—one innovation at a time!
